[钩虫相关皮肤幼虫移行症的治疗：阿苯达唑还是伊维菌素？] - Suppr

Suppr

超能文献

[Treatment of hookworm-related cutaneous larva migrans: albendazole or ivermectin?].

作者信息

Vanhaecke C, Caumes É

出版信息

Ann Dermatol Venereol. 2012 Aug-Sep;139(8-9):518-20. doi: 10.1016/j.annder.2012.05.022. Epub 2012 Jul 3.

DOI:10.1016/j.annder.2012.05.022

PMID:22963959

Abstract

摘要

相似文献

[Treatment of hookworm-related cutaneous larva migrans: albendazole or ivermectin?].

Ann Dermatol Venereol. 2012 Aug-Sep;139(8-9):518-20. doi: 10.1016/j.annder.2012.05.022. Epub 2012 Jul 3.

J Travel Med. 2007 Sep-Oct;14(5):326-33. doi: 10.1111/j.1708-8305.2007.00148.x.

Extensive hookworm-related cutaneous larva migrans in Norwegian travellers to the tropics.

Travel Med Infect Dis. 2008 Jan-Mar;6(1-2):45-7. doi: 10.1016/j.tmaid.2007.09.043. Epub 2007 Nov 5.

Cutaneous larva migrans (hookworm) acquired in Christchurch, New Zealand.

N Z Med J. 2006 Mar 31;119(1231):U1910.

Autochthonous and persistent cutaneous larva migrans in an infant successfully treated by topic albendazole ointment.

J Eur Acad Dermatol Venereol. 2019 Apr;33(4):e163-e164. doi: 10.1111/jdv.15356. Epub 2018 Dec 7.

Unusual migration of cutaneous larva migrans.

J Travel Med. 2022 Nov 4;29(7). doi: 10.1093/jtm/taab197.

Epidemiological and clinical characteristics of hookworm-related cutaneous larva migrans.

Lancet Infect Dis. 2008 May;8(5):302-9. doi: 10.1016/S1473-3099(08)70098-7.

CJEM. 2011 Jul;13(4):230.

A randomized trial of ivermectin versus albendazole for the treatment of cutaneous larva migrans.

Am J Trop Med Hyg. 1993 Nov;49(5):641-4. doi: 10.4269/ajtmh.1993.49.641.

BMJ Case Rep. 2015 Nov 13;2015:bcr2015210165. doi: 10.1136/bcr-2015-210165.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

[Treatment of hookworm-related cutaneous larva migrans: albendazole or ivermectin?].

Ann Dermatol Venereol. 2012 Aug-Sep;139(8-9):518-20. doi: 10.1016/j.annder.2012.05.022. Epub 2012 Jul 3.

J Travel Med. 2007 Sep-Oct;14(5):326-33. doi: 10.1111/j.1708-8305.2007.00148.x.

Extensive hookworm-related cutaneous larva migrans in Norwegian travellers to the tropics.

Travel Med Infect Dis. 2008 Jan-Mar;6(1-2):45-7. doi: 10.1016/j.tmaid.2007.09.043. Epub 2007 Nov 5.

Cutaneous larva migrans (hookworm) acquired in Christchurch, New Zealand.

N Z Med J. 2006 Mar 31;119(1231):U1910.

Autochthonous and persistent cutaneous larva migrans in an infant successfully treated by topic albendazole ointment.

J Eur Acad Dermatol Venereol. 2019 Apr;33(4):e163-e164. doi: 10.1111/jdv.15356. Epub 2018 Dec 7.

Unusual migration of cutaneous larva migrans.

J Travel Med. 2022 Nov 4;29(7). doi: 10.1093/jtm/taab197.

Epidemiological and clinical characteristics of hookworm-related cutaneous larva migrans.

Lancet Infect Dis. 2008 May;8(5):302-9. doi: 10.1016/S1473-3099(08)70098-7.

CJEM. 2011 Jul;13(4):230.

A randomized trial of ivermectin versus albendazole for the treatment of cutaneous larva migrans.

Am J Trop Med Hyg. 1993 Nov;49(5):641-4. doi: 10.4269/ajtmh.1993.49.641.

BMJ Case Rep. 2015 Nov 13;2015:bcr2015210165. doi: 10.1136/bcr-2015-210165.